Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

Jan 1, 2014 (Vol. 34, No. 1)

Asthma Prescription Numbers Slow Down

Monoclonal Antibodies Lead the Pipeline in the Development of Novel Therapeutics

  • The asthma prescription market is slowing as the leading drugs lose patent protection. But leading market researchers BCC and GBI Research each predict moderate ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »